1783 — Maxigen Biotech Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedSmall CapNeutral

Annual balance sheet for Maxigen Biotech, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	210	540	801	433	641
Net Total Accounts Receivable
Net Total Receivables	100	114	100	97.1	104
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	432	784	993	620	830
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	482	465	437	430	433
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	956	1,265	1,448	1,493	1,582
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	86.6	116	152	131	206
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	96.2	123	152	132	207
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	860	1,142	1,296	1,361	1,375
Total Liabilities & Shareholders' Equity	956	1,265	1,448	1,493	1,582
Total Common Shares Outstanding